The Wider Considerations in Closing Chronic Disease Gaps – Focus on
Heart Failure and Implementation

Pupalan      Iyngkaran; Charlotte      Hespe; Fahad      Hanna; John   D   Horowitz; Malcolm      Battersby; Craig      Nelson; Sharon      Andrew; Maximilian   P.   de Courten

Abstract

Background: Heart failure (HF) is predominately a chronic disease. There are overlaps in HF and chronic disease research and care. Chronic disease and HF research are conducted with multiple goals. The overarching goal is “optimized patient outcomes at maximum costeffectiveness”. However, observations on patients can come with many variables; thus, we see differences in clinical translation. This document discusses an argument for three important gaps common to HF and chronic disease, i.e., screening, self-management, and patient-reported outcomes (PRO), and provides a glance of how it could fit into the evidence tree. Pertinent arguments for a framework for health services and models of care are provided as a prelude to future consensus.

Methodology: 1) A preliminary literature review to identify a taxonomy for cardiovascular research, and 2) a review of the published literature describing the translation of research studies into clinical practice for cardiovascular disorders. A spectrum from observational to large randomized controlled trials to post-marketing studies were identified.

Discussion: A brief discussion on traditional research and differences focusing on screening, mixed methods research concepts, and chronic diseases models of care. Six steps to facilitate this: 1) Research design; 2) Research application (translation) i. routine ii. challenges; 3. Transforming research to translational level; 4. Funding and infrastructure; 5. Clinical Centres of Research Excellence (CCRE) and collaboration; 6. Governance and cost-effectiveness.

Conclusion: Implementation research that aims to link research findings to improved patient outcomes in an efficient and effective way is a neglected area. Skills required to perform implementation research are complex. Ways to maximize translational impacts for chronic disease research to clinical practice are described in a HF context.

Keywords: Chronic disease, clinical translation, heart failure, health policy, screening, patient-reported outcomes.

[1]
Smith SC Jr. Risk-reduction therapy: The challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California. Circulation  1996; 93(12): 2205-11.
 [http://dx.doi.org/10.1161/01.CIR.93.12.2205] [PMID: 8925591]

[2]
Krumholz HM, Currie PM, Riegel B, et al. American Heart Association Disease Management Taxonomy Writing Group. A taxonomy for disease management: A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation  2006; 114(13): 1432-45.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177322] [PMID: 16952985]

[3]
Sheridan DJ, Julian DG. Achievements and limitations of evidence-based medicine. J Am Coll Cardiol  2016; 68(2): 204-13.
 [http://dx.doi.org/10.1016/j.jacc.2016.03.600] [PMID: 27386775]

[4]
Guyatt G, Cairns J, Churchill D, et al. Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA  1992; 268(17): 2420-5.
 [http://dx.doi.org/10.1001/jama.1992.03490170092032] [PMID: 1404801]

[5]
Loughlin M, Bluhm R, Buetow S, et al. Reason and value: Making reasoning fit for practice. J Eval Clin Pract  2012; 18(5): 929-37.
 [http://dx.doi.org/10.1111/j.1365-2753.2012.01896.x] [PMID: 22994987]

[6]
DeMaria AN. Clinical trials and clinical judgment. J Am Coll Cardiol  2008; 51(11): 1120-2.
 [http://dx.doi.org/10.1016/j.jacc.2008.02.030] [PMID: 18342233]

[7]
Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: Mind the gap. J Am Coll Cardiol  2010; 56(25): 2077-80.
 [http://dx.doi.org/10.1016/j.jacc.2010.07.013] [PMID: 21144966]

[8]
Bonow RO, Bennett S, Casey DE, Ganiats TG, Hlatky MA, Konstam MA. ACC/AHA clinical performance measures for adults with chronic heart failure. J Am Coll Cardiol  2005; 46(6): 1144-78.
 [http://dx.doi.org/10.1016/j.jacc.2005.07.012] [PMID: 16168305]

[9]
Stone GW, Pocock SJ. Randomized trials, statistics, and clinical inference. J Am Coll Cardiol  2010; 55(5): 428-31.
 [http://dx.doi.org/10.1016/j.jacc.2009.06.066] [PMID: 20117455]

[10]
Ting HH, Shojania KG, Montori VM, Bradley EH. Quality improvement: Science and action. Circulation  2009; 119(14): 1962-74.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.108.768895] [PMID: 19364989]

[11]
Iyngkaran P, Liew D, McDonald P, et al. Phase 4 studies in heart failure - what is done and what is needed? Curr Cardiol Rev  2016; 12(3): 216-30.
 [http://dx.doi.org/10.2174/1573403X12666160606121458] [PMID: 27280303]

[12]
Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med  2007; 356(23): 2388-98.
 [http://dx.doi.org/10.1056/NEJMsa053935] [PMID: 17554120]

[13]
Geboers H, van der Horst M, Mokkink H, et al. Setting up improvement projects in small scale primary care practices: Feasibility of a model for continuous quality improvement. Qual Health Care  1999; 8(1): 36-42.
 [http://dx.doi.org/10.1136/qshc.8.1.36] [PMID: 10557668]

[14]
Geboers H, Mokkink H, van Montfort P, van den Hoogen H, van den Bosch W, Grol R. Continuous quality improvement in small general medical practices: The attitudes of general practitioners and other practice staff. Int J Qual Health Care  2001; 13(5): 391-7.
 [http://dx.doi.org/10.1093/intqhc/13.5.391] [PMID: 11669567]

[15]
Shojania KG, McDonald KM, Wachter RM, Owens DK.  Closing the quality gap: A critical analysis of quality improvement strategies. agency for healthcare research and quality publication No. 04–0051–1. 2004. Available from: http://www.ahrq.gov/downloads/pub/evidence/pdf/qualgap1/qualgap1.pdf

[16]
Hlatky MA, Douglas PS, Cook NL, et al. Future directions for cardiovascular disease comparative effectiveness research: Report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol  2012; 60(7): 569-80.
 [http://dx.doi.org/10.1016/j.jacc.2011.12.057] [PMID: 22796257]

[17]
Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J  2010; 31(5): 525-9.
 [http://dx.doi.org/10.1093/eurheartj/ehp596] [PMID: 20093258]

[18]
Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study. BMJ  1998; 317(7162): 858-61.
 [http://dx.doi.org/10.1136/bmj.317.7162.858] [PMID: 9748183]

[19]
McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines? PLoS Med  2007; 4(8): e250.
 [http://dx.doi.org/10.1371/journal.pmed.0040250] [PMID: 17683197]

[20]
Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ  2008; 336(7650): 924-6.
 [http://dx.doi.org/10.1136/bmj.39489.470347.AD] [PMID: 18436948]

[21]
Warrell DA, Cox TM, Firth JD, Eds. 55 Wald N, Law M Chapter: Medical screeningOxford Textbook of Medicine.  (5th ed.), Oxford University Press 2018.

[22]
Wald NJ. The definition of screening. J Med Screen  2001; 8(1): 1.
 [http://dx.doi.org/10.1136/jms.8.1.1] [PMID: 11373841]

[23]
Rossello X, Dorresteijn JA, Janssen A, et al. Risk prediction tools in cardiovascular disease prevention. Eur Heart J Acute Cardiovasc Care  2020; 9(5): 522-32.
 [http://dx.doi.org/10.1177/2048872619858285] [PMID: 31303009]

[24]
 Available from: https://www.who.int/healthinfo/global_burden_disease/en/ [Accessed on Apr 27, 2022].

[25]
 The Global Health Observatory. Available from: https://www.who.int/data/gho [Accessed on Apr 27, 2022].

[26]
Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL. Moving from heart failure guidelines to clinical practice: Gaps contributing to readmissions in patients with multiple comorbidities and older age. Clin Med Insights Cardiol  2018; 12: 1179546818809358.
 [http://dx.doi.org/10.1177/1179546818809358] [PMID: 30618487]

[27]
Matheny M, McPheeters M, Glasser A, et al. Systematic review of cardiovascular disease risk assessment tools 2011.

[28]
Barratt A, Wyer PC, Hatala R, et al. Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ  2004; 171(4): 353-8.
 [http://dx.doi.org/10.1503/cmaj.1021197] [PMID: 15313996]

[29]
Wallace ML, Ricco JA, Barrett B. Screening strategies for cardiovascular disease in asymptomatic adults. Prim Care  2014; 41(2): 371-97.
 [http://dx.doi.org/10.1016/j.pop.2014.02.010] [PMID: 24830613]

[30]
Iyngkaran P, Chan W, Liew D, et al. Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency? World J Methodol  2019; 9(1): 1-19.
 [http://dx.doi.org/10.5662/wjm.v9.i1.1] [PMID: 30705870]

[31]
Ho JE, Magnani JW. The MESA heart failure risk score: Can’t we do more? Heart  2015; 101(1): 7-9.
 [http://dx.doi.org/10.1136/heartjnl-2014-306459] [PMID: 25387949]

[32]
Kannel WB, D’Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med  1999; 159(11): 1197-204.
 [http://dx.doi.org/10.1001/archinte.159.11.1197] [PMID: 10371227]

[33]
Butler J, Kalogeropoulos A, Georgiopoulou V, et al. Health ABC Study. Incident heart failure prediction in the elderly: The health ABC heart failure score. Circ Heart Fail  2008; 1(2): 125-33.
 [http://dx.doi.org/10.1161/CIRCHEARTFAILURE.108.768457] [PMID: 19777072]

[34]
Agarwal SK, Chambless LE, Ballantyne CM, et al. Prediction of incident heart failure in general practice: The Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail  2012; 5(4): 422-9.
 [http://dx.doi.org/10.1161/CIRCHEARTFAILURE.111.964841] [PMID: 22589298]

[35]
Chahal H, Bluemke D, Wu C, et al. Heart failure risk prediction in community dwelling adults: The Multi-Ethnic Study of Atherosclerosis Study. Heart  2015; 101: 58-64.
 [http://dx.doi.org/10.1136/heartjnl-2014-305697] [PMID: 25381326]

[36]
Lyle M, Wan SH, Murphree D. Predictive value of the get with the guidelines heart failure risk score in unselected cardiac intensive care unit patients. J Am Heart Assoc  2020; 9(3)
 [http://dx.doi.org/10.1161/JAHA.119.012439] [PMID: 31986993]

[37]
Jordan JE, Osborne RH. Chronic disease self-management education programs: Challenges ahead. Med J Aust  2007; 186(2): 84-7.
 [http://dx.doi.org/10.5694/j.1326-5377.2007.tb00807.x] [PMID: 17223770]

[38]
Iyngkaran P. Self-managing heart failure in remote australia - translating concepts into clinical practice. Curr Cardiol Rev  2016; 12(4): 270-84.
 [http://dx.doi.org/10.2174/1573403X12666160703183001] [PMID: 27397492]

[39]
Curry LA, Nembhard IM, Bradley EH. Qualitative and mixed methods provide unique contributions to outcomes research. Circulation  2009; 119(10): 1442-52.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.107.742775] [PMID: 19289649]

[40]
Curry LA, Krumholz HM, O’Cathain A, Plano Clark VL, Cherlin E, Bradley EH. Mixed methods in biomedical and health services research. Circ Cardiovasc Qual Outcomes  2013; 6(1): 119-23.
 [http://dx.doi.org/10.1161/CIRCOUTCOMES.112.967885] [PMID: 23322807]

[41]
Iyngkaran P. Northern territory heart failure initiative – clinical audit (NTHFI – CA)- A prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the northern territory - study design and rationale. BMJ Open  2014; 4(1): e004137.
 [http://dx.doi.org/10.1136/bmjopen-2013-004137] [PMID: 24477314]

[42]
Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ. etal. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure. Circulation  2012; 125: 2382-401.
 [PMID: 22528524]

[43]
Spertus JA, Bonow RO, Chan P, et al. ACCF/AHA Task Force on Performance Measures. ACCF/AHA new insights into the methodology of performance measurement: A report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures. Circulation  2010; 122(20): 2091-106.
 [http://dx.doi.org/10.1161/CIR.0b013e3181f7d78c] [PMID: 21060078]

[44]
Bonow RO, et al. Clinical performance measures for adults with chronic heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Circulation  2005; 112: 1853-87.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.105.170072] [PMID: 16160201]

[45]
Iyngkaran P, Hare DL. Heart failure paradigms in the developed world - a reflection - part 1. Curr Cardiol Rev  2021; 17(5): e221021197368.
 [http://dx.doi.org/10.2174/1573403X1705211022154316] [PMID: 34784860]

[46]
Seward JB. Paradigm shift in medical data management: Big data and small data. JACC Cardiovasc Imaging  2017; 10(11): 1304-6.
 [http://dx.doi.org/10.1016/j.jcmg.2016.10.013] [PMID: 28109929]

[47]
Ho CLB, Breslin M, Doust J, Reid CM, Nelson MR. Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study. BMJ Open  2018; 8(3): e017723.
 [http://dx.doi.org/10.1136/bmjopen-2017-017723] [PMID: 29555790]

[48]
 Available from: https://aspree.org/aus/

[49]
Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci  2012; 7: 50.
 [http://dx.doi.org/10.1186/1748-5908-7-50] [PMID: 22651257]

[50]
 Available from: https://www.health.gov.au/initiatives-and-programs/medical-research-future-fund/mrff-research-themes/research-translation [Accessed on Apr 27, 2022].

[51]
 Available from: https://www.health.gov.au/initiatives-and-programs/rapid-applied-research-translation-initiative [Accessed on Apr 27, 2022].

[52]
 Available from: https://www.nhmrc.gov.au/research-policy/research-translation-and-impact  [Accessed on Apr 27, 2022].

[53]
 Available from: https://www.nhmrc.gov.au/research-policy/research-translation-and-impact/annual-nhmrc-research-translation-symposium [Accessed on Apr 27, 2022].

[54]
 Available from: https://www.biocurate.com/ [Accessed on Apr 27, 2022].

[55]
 Available from: https://www.aushsi.org.au [Accessed on Apr 27, 2022].

[56]
Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med  1989; 321(6): 406-12.
 [http://dx.doi.org/10.1056/NEJM198908103210629] [PMID: 2473403]

[57]
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torceptrapib in patients at high risk for coronary events. N Engl J Med  2007; 357: 2180-3.
 [http://dx.doi.org/10.1056/NEJMoa0706628]

[58]
ISIS 2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet  1988; 2: 349-60.

[59]
Iyngkaran P, Majoni W, Cass A, et al. Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base. Heart Lung Circ  2015; 24(6): 536-43.
 [http://dx.doi.org/10.1016/j.hlc.2014.12.007] [PMID: 25637942]

[60]
Iyngkaran P, Kangaharan N, Zimmet H, et al. Heart failure in minority populations - Impediments to optimal treatment in Australian aborigines. Curr Cardiol Rev  2016; 12(3): 166-79.
 [http://dx.doi.org/10.2174/1573403X12666160606115034] [PMID: 27280307]

[61]
Iyngkaran P, Thomas MC, Johnson R, et al. Contextualizing genetics for regional heart failure care. Curr Cardiol Rev  2016; 12(3): 231-42.
 [http://dx.doi.org/10.2174/1573403X12666160606123103] [PMID: 27280306]

[62]
Jones DW, Peterson ED, Bonow RO, et al. Translating research into practice for healthcare providers: The American Heart Association’s strategy for building healthier lives, free of cardiovascular diseases and stroke. Circulation  2008; 118(6): 687-96.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.108.189934] [PMID: 18625892]

[63]
Drozda JP, Bufalino VJ, Fasules JW, et al. ACC 2009 Advocacy position statement: Principles for comparative effectiveness research. J Am Coll Cardiol  2009; 54(18): 1744-6.
 [http://dx.doi.org/10.1016/j.jacc.2009.09.006] [PMID: 19850218]

[64]
Clark AM, Savard LA, Thompson DR. What is the strength of evidence for heart failure disease-management programs? J Am Coll Cardiol  2009; 54(5): 397-401.
 [http://dx.doi.org/10.1016/j.jacc.2009.04.051] [PMID: 19628113]

[65]
Hachamovitch R, Di Carli MF. Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation  2008; 117(21): 2793-801.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.107.714006] [PMID: 18506018]

[66]
Metra M, Dei Cas L, Massie BM. Treatment of heart failure in the elderly: Never say it’s too late. Eur Heart J  2009; 30(4): 391-3.
 [http://dx.doi.org/10.1093/eurheartj/ehp024] [PMID: 19181708]

[67]
Ho PM, Peterson PN, Masoudi FA. Evaluating the evidence: Is there a rigid hierarchy? Circulation  2008; 118(16): 1675-84.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.107.721357] [PMID: 18852378]

[68]
Krumholz HM. Outcomes research: Generating evidence for best practice and policies. Circulation  2008; 118(3): 309-18.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.107.690917] [PMID: 18625906]

[69]
Havranek EP, Mujahid MS, Barr DA, et al. American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council. Social determinants of risk and outcomes for cardiovascular disease: A scientific statement from the American Heart Association. Circulation  2015; 132(9): 873-98.
 [http://dx.doi.org/10.1161/CIR.0000000000000228] [PMID: 26240271]

[70]
Stewart S, Riegel B, Boyd C, et al. Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. Int J Cardiol  2016; 212: 1-10.
 [http://dx.doi.org/10.1016/j.ijcard.2016.03.001] [PMID: 27015641]

[71]
Riegel B, Lee CS, Sochalski J. Developing an instrument to measure heart failure disease management program intensity and complexity. Circ Cardiovasc Qual Outcomes  2010; 3(3): 324-30.
 [http://dx.doi.org/10.1161/CIRCOUTCOMES.109.877324] [PMID: 20484202]

[72]
Zeitz C, Beltrame J.  Case for Action proposal: Appropriateness and performance in the management of cardiovascular disease In Australian hospitals. Submitted by the NHMRC Research Translation Faculty Cardiovascular Health & Stroke Steering Group. 2014. Available from: www.nhmrc.gov.au/research/research-translation/research-translation-faculty/ideas-research-translation-faculty-cases

[73]
Holmes DR. Overcoming the challenges of conducting early feasibility studies of medical devices in the United States. J Am Coll Cardiol  2016; 68: 1908-15.
 [http://dx.doi.org/10.1016/j.jacc.2016.07.769] [PMID: 27765194]

[74]
Gal D, Thijs B, Glänzel W, Sipido KR. A changing landscape in cardiovascular research publication output: Bridging the translational gap. J Am Coll Cardiol  2018; 71(14): 1584-9.
 [http://dx.doi.org/10.1016/j.jacc.2018.01.073] [PMID: 29622166]

[75]
McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med  2003; 348(26): 2635-45.
 [http://dx.doi.org/10.1056/NEJMsa022615] [PMID: 12826639]

Rights & Permissions Print Cite

Article Metrics

31

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573403X18666220512160737	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557

Current Cardiology Reviews

The Wider Considerations in Closing Chronic Disease Gaps – Focus on Heart Failure and Implementation

Abstract

Related Journals

Related Books